Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-24 @ 11:37 PM
NCT ID:
NCT04485156
Eligibility Criteria:
Inclusion Criteria:
* Documented positivity by sputum Xpert MTB/RIF assay
* Administration of current tuberculosis therapy (if any) for no more than 7 days (≤7) at the time of enrolment.
Exclusion Criteria:
* Negative on Xpert MTB/RIF assay
* Resistance to rifampicin as detected by an Xpert MTB/RIF assay
* Known resistance to isoniazid, rifampicin, or pyrazinamide
* HIV positive
* Cancer patient on anti-cancer chemotherapy
* Uncontrolled DM
* Chronic hepatitis, liver cirrhosis
* Any contraindications of drugs to be used
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
85 Years
Study:
NCT04485156
Study Brief:
Protocol Section:
NCT04485156